Asia
Paris-based Sanofi announced it was transferring its listing of American Depositary Shares (ADS) from the New York Stock Exchange (NYSE) to The Nasdaq Global Select Market starting end-of-day December 31, 2018. They will start trading on January 2, 2019.
Company to supply a six months’ stock of ready-to-use medicines in the event of an emergency
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
Scientists from A*STAR’s Bioinformatics Institute (BII), together with collaborators in Amsterdam, have discovered that the evolution of influenza viruses from natural selection is more closely linked to the transmission stage rather than within the human body.
Clinical trial results also suggest that immune responses to flu vaccinations in independent elderly individuals are not affected by their levels of frailty
UAE remains number 1 globally with highest number of accredited health facilities
The Ministry of Health and Prevention organized a seminar on women’s heart health titled ‘Oxygen Plus for your Heart.’ Dr. Muna Al-Kuwari, Director of the Specialized Care Department, and Vice Chair of the Executive committee on Cardiovascular Index, attended the seminar along with representatives from Dubai Media Incorporated, the Ministry of Education, the UAE University, and the National Ambulance.
In an in-depth investigation, STAT reported on behind-the-scenes activities at the Second International Summit on Human Genome Editing at the University of Hong Kong, where He made his announcement.
The U.S. Food and Drug Administration approved another biosimilar. On Friday, the regulatory agency approved Herzuma, a biosimilar to Genentech’s Herceptin developed by South Korea-based Celltrion, Inc. and Israel-based Teva Pharmaceuticals.
PEEK resin VESTAKEEPⓇ Care* from Evonik Resource Efficiency GmbH Performance Foams and Daicel-Evonik Ltd., has been adopted as a sizing jig for pedestoplasty at Ammtec Co., Ltd.
PRESS RELEASES